SUTRO BIOPHARMA
Sutro Biopharma is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
SUTRO BIOPHARMA
Industry:
Biotechnology Information Technology Medical
Founded:
2003-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.sutrobio.com
Total Employee:
51+
Status:
Active
Contact:
650-392-8412
Email Addresses:
[email protected]
Total Funding:
346.61 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
![]()
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
![]()
![]()

Current Employees Featured
![]()

![]()
![]()
![]()

Founder
![]()
Stock Details
Investors List
![]()
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Sutro Biopharma
Vida Ventures
Vida Ventures investment in Series E - Sutro Biopharma
Samsara BioCapital
Samsara BioCapital investment in Series E - Sutro Biopharma
![]()
Merck
Merck investment in Series E - Sutro Biopharma
Skyline Ventures
Skyline Ventures investment in Series E - Sutro Biopharma
Lilly Ventures
Lilly Ventures investment in Series E - Sutro Biopharma
![]()
Centene
Centene investment in Series E - Sutro Biopharma
![]()
Celgene
Celgene investment in Series E - Sutro Biopharma
![]()
SV Health Investors
SV Health Investors investment in Series E - Sutro Biopharma
Nexthera Capital
Nexthera Capital investment in Series E - Sutro Biopharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-08-09 | Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer |
Official Site Inspections
http://www.sutrobio.com Semrush global rank: 3.92 M Semrush visits lastest month: 3.23 K
- Host name: ec2-34-211-233-150.us-west-2.compute.amazonaws.com
- IP address: 34.211.233.150
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
